They found that UA administration reduced the expression of inflammatory cytokines (e.g., IL-6 and TNF-α) and ubiquitin E3 ligases (e.g., MuRF-1, atrogin-1, and MUSA1) and suppressed CKD-induced muscle atrophy (tibialis anterior muscle). The gene discussed is TNF; the disease is chronic kidney disease.